Barcelona, January 26, 2022. Investment in health startups in the BioRegion continues to grow and again surpassed the €200 million mark for the second year in a row, despite the COVID-19 pandemic. In total, companies raised €238 million, the most to date. Venture capital funding was the main driver of this growth, with more than €187 million, or 79% of all capital, three times as much as in 2019.
83% of the venture capital raised was in operations with international investors. In fact, more than 90% of operations worth over €10 million are...
Predicting and establishing the prognosis of diseases is key to controlling them. Biocat will provide support for the 19 research projects in the BioRegion awarded €4 million from the Catalan Ministry of Health to research the pandemic, 6 of which are looking into possible prediction or prognosis methods for this disease. Let’s look at how the centers are focusing their research.
A few days ago, the 19 research projects in the BioRegion awarded €4 million from the Catalan Ministry of Health to research the pandemic, with technical support from Biocat, were announced. Of these projects, 3 are researching potential vaccines for the SARS-CoV-2 virus. Let’s look at the preventive strategies they propose.
Five research projects in the BioRegion of Catalonia are investigating how to take advantage of therapies already in use for other diseases to treat Covid-19. They have received funding from the Catalan Ministry of Health to study this new path towards a possible cure to the pandemic. Let’s look at what they’re working on.